Table 4.
Survey completion rates.
| Survey | Intervention (n = 29) | Control (n = 27) |
|---|---|---|
| EPhect MQ | 29 (100%) | 27 (100%) |
| BPI | ||
| Baseline | 27 (93.0%) | 22 (84.6%) |
| End | 27 (93.0%) | 25 (93.0%) |
| 3-mo. follow-up | 16 (55.1%) | 11 (40.7%) |
| PSS-14 | ||
| Baseline | 29 (100%) | 25 (96.0%) |
| End | 26 (89.7%) | 23 (85.0%) |
| 3-mo. follow-up | 17 (59.0%) | 11 (40.7%) |
| EHP-30 | ||
| Baseline | 29 (100%) | 20 (76.9%) |
| End | 26 (89.7%) | 26 (96.3%) |
| 3-mo. follow-up | 17 (58.6%) | 14 (51.9%) |
| Clinical history | 28 (97.0%) | 25 (93.0%) |
| GAD-7 | ||
| Baseline | 29 (100%) | 27 (100%) |
| End | 29 (100%) | 27 (100%) |
| 3-mo. follow-up | 19 (65.5%) | N/A |
| PHQ-8 | ||
| Baseline | 29 (100%) | 27 (100%) |
| End | 29 (100%) | 27 (100%) |
| 3-mo. follow-up | 19 (65.5%) | N/A |
Summary of completion rates of the study surveys. EPhect-MQ, endometriosis phenome project minimal questionnaire; BPI, brief pain inventory; PSS-14, perceived stress scale 14; EHP-30, endometriosis health profile 30; GAD-7, general anxiety disorder 7; PHQ8, patient health questionnaire depression scale 8; mo. = month.